Barr gets OK to buy Shire's Adderall

Sept. 28, 2006 at 12:03 PM

WOODCLIFF LAKE, N.J., Sept. 28 (UPI) -- Barr said Thursday it was moving ahead on a deal to acquire Shire's Adderall for $63 million, with a re-launch later this year.

The deal was initially announced in August, but federal law required the companies to allow a 30-day waiting period to elapse before proceeding. The waiting period expired Sept. 27 without any objections from the Federal Trade Commission.

Under the terms of the deal, Barr's subsidiary Duramed will purchase Shire's attention-deficit/hyperactivity disorder treatment Adderall for $63 million. Duramed will re-launch Adderall in the quarter ending Dec. 31, 2006.

Related UPI Stories
Latest Headlines
Trending Stories
One arrested after Philadelphia college lockdown
Boehner delays House vote for new speaker
NASA releases thousands of Apollo mission photos on Flickr
Snowden: U.S. won't respond to offers to serve prison time
FDA approves new treatment for advanced lung cancer